The growing disease burden of diabetes mellitus is an important public health concern,
affecting over 400 million people globally. This epidemic, if not controlled in time, leads to …

The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A
century later, availability and affordability of insulin remain a challenge in many parts of the …

This analysis examines the potential of “cultured meat” products made from edible animal
cell culture to measurably displace the global consumption of conventional meat …

Abstract The Internet of Medical Things (IoMT) is the gathering and implementation of
healthcare tools connected to public healthcare technology infrastructure via Internet-based …

The occurrence and development of cardiovascular complications are predominantly
responsible for the increased morbidity and mortality observed in patients with diabetes …

Aims To evaluate the efficacy and safety of imeglimin for up to 52 weeks as combination
therapy with insulin in Japanese patients with type 2 diabetes. Materials and Methods This …

The growing incidence of type 2 diabetes (T2D) is a significant health concern, representing
90% of diabetes cases worldwide. As the disease progresses, resultant insulin deficiency …

Biosensors that continuously measure circulating biomolecules in real time could provide
insights into the health status of patients and their response to therapeutics. But biosensors …

To frame the substantial prevalence of type 2 diabetes (T2D) as a 'Modern Preventable
Pandemic'(MPP) and present certain replicable policy lessons from the COVID-19 crisis to …

The pancreatic peptide hormone insulin, first discovered exactly 100 years ago, is essential
for glycemic control and is used as a therapeutic for the treatment of type 1 and, increasingly …